Cargando…

Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects

A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokarska-Schlattner, Malgorzata, Epand, Raquel F., Meiler, Flurina, Zandomeneghi, Giorgia, Neumann, Dietbert, Widmer, Hans R., Meier, Beat H., Epand, Richard M., Saks, Valdur, Wallimann, Theo, Schlattner, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422282/
https://www.ncbi.nlm.nih.gov/pubmed/22912820
http://dx.doi.org/10.1371/journal.pone.0043178
_version_ 1782241027840540672
author Tokarska-Schlattner, Malgorzata
Epand, Raquel F.
Meiler, Flurina
Zandomeneghi, Giorgia
Neumann, Dietbert
Widmer, Hans R.
Meier, Beat H.
Epand, Richard M.
Saks, Valdur
Wallimann, Theo
Schlattner, Uwe
author_facet Tokarska-Schlattner, Malgorzata
Epand, Raquel F.
Meiler, Flurina
Zandomeneghi, Giorgia
Neumann, Dietbert
Widmer, Hans R.
Meier, Beat H.
Epand, Richard M.
Saks, Valdur
Wallimann, Theo
Schlattner, Uwe
author_sort Tokarska-Schlattner, Malgorzata
collection PubMed
description A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathies and a plethora of neurodegenerative diseases. Additionally, Cr and its cyclic analogues have been proposed for anti-cancer treatment. The mechanisms involved in these pleiotropic effects are still controversial and far from being understood. The reversible conversion of Cr and ATP into PCr and ADP by creatine kinase, generating highly diffusible PCr energy reserves, is certainly an important element. However, some protective effects of Cr and analogues cannot be satisfactorily explained solely by effects on the cellular energy state. Here we used mainly liposome model systems to provide evidence for interaction of PCr and PcCr with different zwitterionic phospholipids by applying four independent, complementary biochemical and biophysical assays: (i) chemical binding assay, (ii) surface plasmon resonance spectroscopy (SPR), (iii) solid-state (31)P-NMR, and (iv) differential scanning calorimetry (DSC). SPR revealed low affinity PCr/phospholipid interaction that additionally induced changes in liposome shape as indicated by NMR and SPR. Additionally, DSC revealed evidence for membrane packing effects by PCr, as seen by altered lipid phase transition. Finally, PCr efficiently protected against membrane permeabilization in two different model systems: liposome-permeabilization by the membrane-active peptide melittin, and erythrocyte hemolysis by the oxidative drug doxorubicin, hypoosmotic stress or the mild detergent saponin. These findings suggest a new molecular basis for non-energy related functions of PCr and its cyclic analogue. PCr/phospholipid interaction and alteration of membrane structure may not only protect cellular membranes against various insults, but could have more general implications for many physiological membrane-related functions that are relevant for health and disease.
format Online
Article
Text
id pubmed-3422282
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34222822012-08-21 Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects Tokarska-Schlattner, Malgorzata Epand, Raquel F. Meiler, Flurina Zandomeneghi, Giorgia Neumann, Dietbert Widmer, Hans R. Meier, Beat H. Epand, Richard M. Saks, Valdur Wallimann, Theo Schlattner, Uwe PLoS One Research Article A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathies and a plethora of neurodegenerative diseases. Additionally, Cr and its cyclic analogues have been proposed for anti-cancer treatment. The mechanisms involved in these pleiotropic effects are still controversial and far from being understood. The reversible conversion of Cr and ATP into PCr and ADP by creatine kinase, generating highly diffusible PCr energy reserves, is certainly an important element. However, some protective effects of Cr and analogues cannot be satisfactorily explained solely by effects on the cellular energy state. Here we used mainly liposome model systems to provide evidence for interaction of PCr and PcCr with different zwitterionic phospholipids by applying four independent, complementary biochemical and biophysical assays: (i) chemical binding assay, (ii) surface plasmon resonance spectroscopy (SPR), (iii) solid-state (31)P-NMR, and (iv) differential scanning calorimetry (DSC). SPR revealed low affinity PCr/phospholipid interaction that additionally induced changes in liposome shape as indicated by NMR and SPR. Additionally, DSC revealed evidence for membrane packing effects by PCr, as seen by altered lipid phase transition. Finally, PCr efficiently protected against membrane permeabilization in two different model systems: liposome-permeabilization by the membrane-active peptide melittin, and erythrocyte hemolysis by the oxidative drug doxorubicin, hypoosmotic stress or the mild detergent saponin. These findings suggest a new molecular basis for non-energy related functions of PCr and its cyclic analogue. PCr/phospholipid interaction and alteration of membrane structure may not only protect cellular membranes against various insults, but could have more general implications for many physiological membrane-related functions that are relevant for health and disease. Public Library of Science 2012-08-17 /pmc/articles/PMC3422282/ /pubmed/22912820 http://dx.doi.org/10.1371/journal.pone.0043178 Text en © 2012 Tokarska-Schlattner et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tokarska-Schlattner, Malgorzata
Epand, Raquel F.
Meiler, Flurina
Zandomeneghi, Giorgia
Neumann, Dietbert
Widmer, Hans R.
Meier, Beat H.
Epand, Richard M.
Saks, Valdur
Wallimann, Theo
Schlattner, Uwe
Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects
title Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects
title_full Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects
title_fullStr Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects
title_full_unstemmed Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects
title_short Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects
title_sort phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422282/
https://www.ncbi.nlm.nih.gov/pubmed/22912820
http://dx.doi.org/10.1371/journal.pone.0043178
work_keys_str_mv AT tokarskaschlattnermalgorzata phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT epandraquelf phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT meilerflurina phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT zandomeneghigiorgia phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT neumanndietbert phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT widmerhansr phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT meierbeath phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT epandrichardm phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT saksvaldur phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT wallimanntheo phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects
AT schlattneruwe phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects